![90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology 90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology](https://tech.snmjournals.org/sites/default/files/highwire/jnmt/48/3.cover-source.jpg)
90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology
![Pharmaceutics | Free Full-Text | Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside | HTML Pharmaceutics | Free Full-Text | Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00599/article_deploy/html/images/pharmaceutics-13-00599-ag.png)
Pharmaceutics | Free Full-Text | Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside | HTML
![PDF) Three-Dimensional Patient-Specific Dosimetry in Radioimmunotherapy with Y-90-Ibritumomab-Tiuxetan PDF) Three-Dimensional Patient-Specific Dosimetry in Radioimmunotherapy with Y-90-Ibritumomab-Tiuxetan](https://i1.rgstatic.net/publication/221783333_Three-Dimensional_Patient-Specific_Dosimetry_in_Radioimmunotherapy_with_Y-90-Ibritumomab-Tiuxetan/links/57762c3108ae4645d60d4430/largepreview.png)
PDF) Three-Dimensional Patient-Specific Dosimetry in Radioimmunotherapy with Y-90-Ibritumomab-Tiuxetan
![Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4bb5d600-dcb0-448e-bfdc-fd57b99cf0b0/gr2.jpg)
Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics
![Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned? - ScienceDirect Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842816301640-gr1.jpg)
Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned? - ScienceDirect
![PDF) Administration Guidelines for Radioimmunotherapy of Non-Hodgkin's Lymphoma with 90Y-Labeled Anti-CD20 Monoclonal Antibody PDF) Administration Guidelines for Radioimmunotherapy of Non-Hodgkin's Lymphoma with 90Y-Labeled Anti-CD20 Monoclonal Antibody](https://i1.rgstatic.net/publication/11509955_Administration_Guidelines_for_Radioimmunotherapy_of_Non-Hodgkin's_Lymphoma_with_90Y-Labeled_Anti-CD20_Monoclonal_Antibody/links/0c960529dc89867c9b000000/largepreview.png)
PDF) Administration Guidelines for Radioimmunotherapy of Non-Hodgkin's Lymphoma with 90Y-Labeled Anti-CD20 Monoclonal Antibody
![Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/997b0bcc-00b2-46dd-a27b-e7ed99eb3d26/caac354-fig-0001-m.jpg)
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology 90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology](https://tech.snmjournals.org/content/jnmt/48/3/274/F1.large.jpg)
90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices | Journal of Nuclear Medicine Technology
![Emerging classes of armed antibody therapeutics against cancer - MedChemComm (RSC Publishing) DOI:10.1039/C3MD00360D Emerging classes of armed antibody therapeutics against cancer - MedChemComm (RSC Publishing) DOI:10.1039/C3MD00360D](https://pubs.rsc.org/image/article/2014/MD/c3md00360d/c3md00360d-f4_hi-res.gif)
Emerging classes of armed antibody therapeutics against cancer - MedChemComm (RSC Publishing) DOI:10.1039/C3MD00360D
![Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/855747/6254327/gr1.jpg)
Logistics of therapy with the ibritumomab tiuxetan regimen - International Journal of Radiation Oncology, Biology, Physics
![90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma | Journal of Nuclear Medicine Technology 90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma | Journal of Nuclear Medicine Technology](https://tech.snmjournals.org/content/jnmt/31/2/61/F4.large.jpg)
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma | Journal of Nuclear Medicine Technology
![Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/e9916b00-e273-4ab6-8e52-fc74504f99f7/caac.v72.4.cover.jpg?trick=1658130136651)
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings - Connor - 2006 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![Genes | Free Full-Text | Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients | HTML Genes | Free Full-Text | Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients | HTML](https://www.mdpi.com/genes/genes-13-00951/article_deploy/html/images/genes-13-00951-ag.png)